Abstract
Justification: Tetanus, fatal disease, still exists in Madagascar in spite of the vaccination sessions of mass, and attacks also the children. Objective: To describe the epidemiology, the clinical aspect, the treatments and the evolutions of infantile tetanus. Patients and methods: Retrospective study in the pediatric intensive care unit of the University Hospital of Tamatave, on the cases listed during four years (2013-2016). Results: Twenty-seven cases were recensed, with an average age of 10.8 years old and a sex ratio (M/W) equal to 6. Only forty-one percent were already vaccinated before the one year age. No child of more than 11 years-old profited from vaccine recall. The stain of the wound after the ablation of flea was the most frequent cause (76%). Tetanus was generalized in 80%, including 44.4% with respiratory disorder having required intubation. All the children presented hyperthermia above 38°C at the entry and 63% higher or equal to 40°C. Sedation by diazepam, used at all children, was used with an average amount of 4 mg/kg/day. The beta-lactamine antibiotics were used in 100% of the cases. The antitetanus serum was administered at 3000 IU/day. Nosocomial infections occurred in 61%. The mean hospitalization duration was around 11 days. Mortality was 47%. Discussion and conclusion: The vaccine recalls are still negligent in the old children, making these latter vulnerable. Mortality is especially due to superinfections and denutrition.
Highlights
IntroductionNon-contagious disease caused by Clostridium tetani, known as Nicolaier's bacillus
Tetanus is an infectious, non-contagious disease caused by Clostridium tetani, known as Nicolaier's bacillus
27 cases of childhood tetanus were collected from 1026 inpatients in pediatric intensive care units, representing a hospital prevalence of 2.6%
Summary
Non-contagious disease caused by Clostridium tetani, known as Nicolaier's bacillus. It is a ubiquitous anaerobic telluric bacillus that produces toxins: tetanolysin and tetanospasmin. Tetanus is a fatal but completely preventable disease through vaccination and the administration of anti-tetanus serum as post-exposure prophylaxis [1]. In developed countries, this condition has become increasingly rare. The number of confirmed cases of tetanus identified since 2006 has ranged from 49 to 167 per year, with a downward trend. In 2014, the total incidence reported in the European Union was 0.01 cases per 100,000 inhabitants [2]
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: Pediatric Review: International Journal of Pediatric Research
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.